This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

AstraZeneca and Daiichi Sankyo voluntarily withdraw regulatory filing for Dato-DXd in nonsquamous non-small cell lung cancer ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

Intramuscular Route Expected to Hold the Largest Share in Viral Vaccines AdministrationDublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by ...

Merck will encounter some Keytruda-related issues toward the end of the decade, but the company's business and pipeline are ...

Amid our daily coverage of the news you need to know, however, a certain kind of story seemed to resonate most with our ...

The Ervebo vaccine uses a modified virus to produce antibodies against Ebola ANALYSIS | YAP BOUM | The Ebola virus devastated ...

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the ...

Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, ...

New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug ...

India's pharmaceutical industry is poised for a dramatic transformation by 2025, driven by AI, machine learning, and ...

The FDA is reportedly proposing that cosmetic products containing talc be tested for the presence of asbestos, a known ...